Mapping of the antigenic determinants of the Leishmania infantum gp63 protein recognized by antibodies elicited during canine visceral leishmaniasis
- PMID: 9172421
Mapping of the antigenic determinants of the Leishmania infantum gp63 protein recognized by antibodies elicited during canine visceral leishmaniasis
Abstract
The gp63 gene encoding the major surface antigen of Leishmania infantum has been cloned and sequenced. In spite of the overall sequence homology with the gp63 genes from other Leishmania species, particularly with the constitutively expressed Leishmania chagasi Gp63 gene, the carboxy-terminal ends of these genes are clearly divergent (62% homology). To study the prevalence of anti-gp63 antibodies in the sera from dogs with visceral leishmaniasis, a recombinant L. infantum gp63 protein was expressed in Escherichia coli. It was found that 100% of the sera from these dogs recognized the recombinant gp63 protein, suggesting that it must function as a potent B cell immunogen during natural canine visceral leishmaniasis. However, heterogeneity in the level of response was observed. Fine mapping of the antigenic determinants was performed by means of 6 overlapping subfragments of the gp63 protein and by the use of a library of synthetic peptides. The data showed that there is some degree of immunological restriction in the recognition of the protein since reactivity was observed preferentially against the most divergent region. The epitope mapping of this region showed 2 immunodominant peptides the response to which seems to be preferentially of the IgG2 type.
Similar articles
-
Mapping of the linear antigenic determinants from the Leishmania infantum histone H2A recognized by sera from dogs with leishmaniasis.Immunol Lett. 1995 Dec;48(3):209-14. doi: 10.1016/0165-2478(95)02473-5. Immunol Lett. 1995. PMID: 8867853
-
Identification and characterization of new Leishmania promastigote surface antigens, LaPSA-38S and LiPSA-50S, as major immunodominant excreted/secreted components of L. amazonensis and L. infantum.Infect Genet Evol. 2014 Jun;24:1-14. doi: 10.1016/j.meegid.2014.02.017. Epub 2014 Mar 7. Infect Genet Evol. 2014. PMID: 24614507
-
Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.Vaccine. 2007 May 22;25(21):4223-34. doi: 10.1016/j.vaccine.2007.02.083. Epub 2007 Mar 15. Vaccine. 2007. PMID: 17395339 Clinical Trial.
-
Evolution and expression of the Leishmania surface proteinase (gp63) gene locus.Infect Agents Dis. 1993 Feb;2(1):25-34. Infect Agents Dis. 1993. PMID: 8162351 Review.
-
A new Leishmania-specific hypothetical protein and its non-described specific B cell conformational epitope applied in the serodiagnosis of canine visceral leishmaniasis.Parasitol Res. 2016 Apr;115(4):1649-58. doi: 10.1007/s00436-016-4904-x. Epub 2016 Jan 19. Parasitol Res. 2016. PMID: 26782811 Review.
Cited by
-
Nonrandom spatial distribution of synonymous substitutions in the GP63 gene from Leishmania.Genetics. 2000 Aug;155(4):1683-92. doi: 10.1093/genetics/155.4.1683. Genetics. 2000. PMID: 10924466 Free PMC article.
-
In silico characterization of multiple genes encoding the GP63 virulence protein from Leishmania braziliensis: identification of sources of variation and putative roles in immune evasion.BMC Genomics. 2019 Feb 7;20(1):118. doi: 10.1186/s12864-019-5465-z. BMC Genomics. 2019. PMID: 30732584 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions